A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults
Clinical trial NCT05969236 · COMPLETED
Trial details
- NCT number
- NCT05969236
- Sponsor
- Shanghai Medinno Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-06
- Primary completion
- 2024-04-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.